Rankings
▼
Calendar
VTRS FY 2017 Earnings — Viatris Inc. Revenue & Financial Results | Market Cap Arena
VTRS
Viatris Inc.
$16B
FY 2017 Earnings
Healthcare
Drug Manufacturers - Specialty & Generic
Income Statement
Revenue
$11.9B
+7.5% YoY
Gross Profit
$4.8B
40.2% margin
Operating Income
$1.4B
12.1% margin
Net Income
$696M
5.8% margin
EPS (Diluted)
$1.30
Cash Flow
Operating Cash Flow
$2.1B
Free Cash Flow
$1.8B
Stock-Based Comp.
$75M
Balance Sheet
Total Assets
$35.8B
Total Liabilities
$22.5B
Stockholders' Equity
$13.3B
Cash & Equivalents
$292M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$11.9B
$11.1B
+7.5%
Gross Profit
$4.8B
$4.7B
+1.8%
Operating Income
$1.4B
$699M
+105.5%
Net Income
$696M
$480M
+45.0%
← Q4 2016
All Quarters
Q1 2017 →